To view journal scope & editors or submit a manuscript, please select a specific journal:
CIG Media Group Announces 2008 Impact Factor for Clinical Colorectal Cancer
CIG Media Group, LP has announced the debut ISI Impact Factor of 2.724 for Clinical Colorectal Cancer. This is the first Impact Factor for a journal dedicated to disseminating cutting-edge data to the practicing clinician by providing physicians and healthcare professionals with the most up-to-date, clinically relevant information available.
“It is clear that our publication fills a need within the oncology space, represented by our new Impact Factor of 2.724. Because this is the first Impact Factor for the journal, I am delighted to see that our hard work and efforts have been embraced by the oncology community” says Dr. Edward Chu, Editor-in-Chief of Clinical Colorectal Cancer.
Clinical Colorectal Cancer is a peer-reviewed quarterly journal that publishes original articles describing various aspects of clinical and translational research of colorectal cancer and other gastrointestinal malignancies. The journal publishes a variety of content including comprehensive reviews and original studies. Clinical Colorectal Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of colorectal cancer and other gastrointestinal malignancies, with an emphasis is on recent scientific developments. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.
About CIG Media Group, LP